Rigel Pharmaceuticals, Inc.(RIGL)- NASDAQ
  • Michael Blake Kuritz | Send Message 19 Feb

    $RIGL is more attractive now than ever. They have a great deal with $BMY and it will pay out
      • usmi | Send Message 24 Apr 2015

        New High/Low: $RIGL $NPD $DXM $FNJN http://bit.ly/1I5jERW
          • PatrickTS | Send Message 24 Feb 2015

            Interesting tickers for today: $CAPN $BIOC $RIGL $TSEM $GBSM
              • Mike Zaman | Send Message 23 Feb 2015

                Biocept (BIOC) Soars On Liquid Biopsy Appreciation, Rigel Pharmaceuticals (RIGL)... $BIOC, $RIGL, $BMY http://seekingalpha.com/p/28ptm
                  • Yiwen Nni | Send Message 23 Feb 2015

                    $RIGL Enters Collaboration with Bristol-Myers http://bit.ly/1Bd3lkw
                      • Shane Skinner | Send Message 17 Mar 2014

                        Trade Updates - Rigel Pharma, KaloBios Pharma $KBIO, $RIGL http://seekingalpha.com/p/1n73t
                          • Shane Skinner | Send Message 7 Mar 2014

                            Daily Dose - Navidea, Rigel $NAVB, $RIGL http://seekingalpha.com/p/1mm4t
                              • Ryan Mallory | Send Message 8 Apr 2013

                                Fuinhaz Setups for April 8 2013 | $AMRN $BCRX $FSLR $GLUU $PERI $RIGL $SRPT $SVA $ZNGA | http://bit.ly/10MTLwT
                                  • ZetaKap | Send Message 29 Aug 2012

                                    4 Low-Debt Pharmaceutical Stocks Backed By Analysts http://bit.ly/Ou7S51 $ASTX $ECYT $IPXL $RIGL @ZetaKap
                                      • ZetaKap | Send Message 1 Aug 2012

                                        3 Analyst-Backed Pharmaceutical Stocks With Great Projections http://bit.ly/NTzNgg $AEGR $KERX $RIGL @ZetaKap
                                          Company Description
                                          Rigel Pharmaceuticals, Inc. is a clinical stage drug development company. It discovers and develops novel, targeted drugs in the therapeutic areas of immunology, oncology and immune oncology. The company focuses on intracellular signaling pathways and related targets that are critical to disease... More
                                          Sector: Healthcare
                                          Industry: Drug Manufacturers - Major
                                          Country: United States